Matches in Nanopublications for { ?s ?p "[We propose a model in which incomplete gain or loss of methylation at this CTCF-binding site during tumorigenesis explains the complex and often conflicting expression patterns of IGF2 and H19 in tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP383956.RA7hn5vsJ1CIPBvve4px3foeSBKUhRv594Vg_F4WcZqtY130_assertion description "[We propose a model in which incomplete gain or loss of methylation at this CTCF-binding site during tumorigenesis explains the complex and often conflicting expression patterns of IGF2 and H19 in tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383956.RA7hn5vsJ1CIPBvve4px3foeSBKUhRv594Vg_F4WcZqtY130_provenance.
- assertion description "[We propose a model in which incomplete gain or loss of methylation at this CTCF-binding site during tumorigenesis explains the complex and often conflicting expression patterns of IGF2 and H19 in tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We propose a model in which incomplete gain or loss of methylation at this CTCF-binding site during tumorigenesis explains the complex and often conflicting expression patterns of IGF2 and H19 in tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP850677.RAHlgl8SqH3U7l7F9bncihIldHubPF-0Y-5AVs9NVIwRM130_assertion description "[We propose a model in which incomplete gain or loss of methylation at this CTCF-binding site during tumorigenesis explains the complex and often conflicting expression patterns of IGF2 and H19 in tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850677.RAHlgl8SqH3U7l7F9bncihIldHubPF-0Y-5AVs9NVIwRM130_provenance.
- NP383953.RAnhlyoo3Bdp7OSZbMh2N8k0CiVzJYD6-grOCn0mLpFZw130_assertion description "[We propose a model in which incomplete gain or loss of methylation at this CTCF-binding site during tumorigenesis explains the complex and often conflicting expression patterns of IGF2 and H19 in tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383953.RAnhlyoo3Bdp7OSZbMh2N8k0CiVzJYD6-grOCn0mLpFZw130_provenance.